Drugs / MT-102
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01238107 | Apr 2011 → May 2013 | — | Akamis Bio | Completed | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MT-102 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01238107 ↗ |